Prescribing heroin

Area of Science:

• Addiction Medicine
• Pharmacology
• Public Health Policy

Background:

• UK guidelines advocate for injectable heroin and methadone for opiate dependence treatment.
• The historical
• British system
• of heroin prescription has international recognition.
• A prescriber licensing system, implemented in 1965, significantly reduced heroin treatment for opiate addiction.

Purpose of the Study:

• To review current British practices in opiate dependence treatment in light of recent international trials.
• To compare British treatment approaches with those in Switzerland and the Netherlands.
• To assess the future viability of the current British system for heroin-assisted treatment.

Main Methods:

• Review of UK guidelines and historical practices regarding prescription of heroin and methadone.
• Analysis of recent trials in Switzerland and the Netherlands.
• Comparative assessment of British practice against continental European models.

Main Results:

• Injectable heroin and methadone are supported by recent UK guidelines for opiate dependence.
• The historical
• British system
• of heroin prescription has evolved significantly since 1965 due to licensing.
• British practice may continue to differ from continental Europe, especially regarding supervised injecting.

Conclusions:

• The future of the current British approach to opiate dependence treatment, particularly heroin-assisted therapy, is uncertain.
• Adequate funding is crucial for the continuation of these treatment services.
• Divergence in practice, especially in supervised injecting, is likely to persist between the UK and continental Europe.